TriRx Pharmaceutical Services Executive and Leadership Team

Timothy Tyson, the Chairman & Chief Executive Officer at TriRx Pharmaceutical Services, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the integration of development, analytics, and manufacturing capabilities, Tyson ensures the company meets the complex demands of global pharmaceutical clients. This leadership role involves constant engagement with the Board to align operational goals with market expansion objectives. Timothy Tyson drives the pursuit of excellence in both sterile and non-sterile product manufacturing, ensuring that all facilities maintain rigorous quality standards. Through the optimization of internal processes and the cultivation of strategic partnerships, the Chief Executive Officer secures the company's position as a premier contract development and manufacturing organization. Tyson maintains a focus on scaling production capacity to support the commercialization efforts of diverse pharmaceutical partners across international markets, ultimately fostering sustainable growth and operational efficiency within the competitive pharmaceutical landscape.

Keith Lyon, the Executive Vice President & Chief Financial Officer at TriRx Pharmaceutical Services, governs the financial health and fiscal strategy of the organization. Overseeing capital allocation, budgeting, and financial reporting, the Chief Financial Officer ensures the company maintains the necessary resources to support its manufacturing and development initiatives. This leadership role involves analyzing market trends to inform investment decisions regarding facility upgrades and technology acquisitions. Keith Lyon manages the financial risks associated with global operations, ensuring stability across all business units. By providing data-driven insights to the Board, the Chief Financial Officer supports informed decision-making regarding long-term growth and commercialization strategies. Lyon directs the financial planning processes that enable the company to remain competitive in the pharmaceutical manufacturing sector. Through the rigorous management of assets and liabilities, Lyon secures the financial foundation required to sustain the company's commitment to delivering advanced, high-quality pharmaceutical services to a global client base.

Jim Scandura, the Co-Founder & Director & Executive Vice President & Chief Operating Officer at TriRx Pharmaceutical Services, manages the daily operational execution across all manufacturing sites. Overseeing the technical infrastructure and production workflows, the Chief Operating Officer ensures that sterile and non-sterile manufacturing processes adhere to strict regulatory requirements. This role involves coordinating cross-functional teams to streamline packaging solutions and animal health injectable production. Jim Scandura architects the operational framework that allows the company to scale effectively while maintaining high output quality. By monitoring facility performance and resource allocation, the Chief Operating Officer drives continuous improvement in manufacturing throughput. Scandura collaborates with the executive team to translate strategic objectives into actionable production plans, ensuring that the organization delivers reliable, high-quality services to pharmaceutical clients. Through meticulous oversight of operational logistics, Scandura maintains the integrity of the supply chain and supports the company's mission to provide advanced pharmaceutical manufacturing solutions.

Richard Mark, the Chief Human Resources Officer at TriRx Pharmaceutical Services, leads the talent acquisition, organizational development, and employee engagement strategies. Overseeing the human capital requirements across all manufacturing facilities, the Chief Human Resources Officer ensures the company attracts and retains the specialized expertise necessary for sterile and non-sterile pharmaceutical production. This role involves designing training programs that align with the technical demands of the pharmaceutical industry. Richard Mark architects the corporate culture to foster innovation, safety, and operational excellence among the workforce. By implementing performance management systems, the Chief Human Resources Officer drives accountability and professional growth throughout the organization. Mark collaborates with other C-suite leaders to ensure that staffing levels and organizational structures support the company's strategic objectives. Through the development of robust human resources policies, Mark ensures that the company maintains a highly skilled and motivated team capable of meeting the complex needs of pharmaceutical clients worldwide.